Skip to main content
. Author manuscript; available in PMC: 2021 Jul 21.
Published in final edited form as: J Neurosurg. 2020 Feb 7;134(3):862–869. doi: 10.3171/2019.12.JNS192746

Table 2.

Baseline characteristics.

Variable Overall* Patients = 80
UIAs = 102
Enhancing UIAs (n = 64) Non-enhancing UIAs (n = 38)
Age (in years, mean ± SD) 64.5 ± 12.2 66.6 ± 11.9 59.9 ± 10.3
Women (%) 64 (80) 50 (78.1) 32 (84.2)
Current smoking (%) 42 (52.5) 33 (51.6) 22 (57.9)
Hypertension (%) 45 (56.3) 36 (56.3) 23 (60.5)
Diabetes (%) 12 (15) 10 (15.6) 4 (10.5)
Hyperlipidemia (%) 34 (42.5) 25 (39.1) 16 (42.1)
Family history of IAs (%) 7 (8.75) 5 (7.8) 5 (13.2)
Size (in mm, mean, range) 8.7 (3–31) 10.8 (3–31) 5.1 (3–11)
- ≥7 mm (%) 54 (52.9) 44 (68.8) 10 (26.3)
- <7 mm (%) 48 (47.1) 20 (31.3) 28 (73.7)
Location
- Internal carotid artery (%) 25 (24.5) 22 (34.4) 3 (7.9)
- Anterior communicating artery (%) 16 (15.7) 7 (10.9) 9 (23.7)
- Anterior cerebral artery (%) 5 (4.9) 3 (4.7) 2 (5.3)
- Middle cerebral artery (%) 27 (26.5) 14 (26.5) 13 (34.2)
- Posterior communicating artery (%) 5 (4.9) 3 (4.7) 2 (5.3)
- Basilar artery (%) 19 (18.6) 12 (18.8) 7 (18.4)
- Superior cerebellar (%) 3 (2.9) 1 (1.6) 2 (5.3)
- Vertebral artery (%) 2 (2.0) 2 (3.1) 0 (0)

CRstalk: aneurysm-to-pituitary stalk ratio; mm: millimeters; UIAs: unruptured intracranial aneurysms; SD: standard deviation

*

In overall counts, frequencies for demographics are calculated over total number of patients (N=80), whereas size and location are presented over total number of UIAs (N=102).

According to CRstalk ≥ 0.60 using maximal SI values.